Hester Biosciences 

₹2,365.00
0
-₹26.00-1.09% 04:11 今天

統計

當日最高
2,405.4
當日最低
2,353.3
52週高點
2,683.6
52週低點
1,239.3
成交量
2,855
平均成交量
30,571
市值
20.12B
本益比
33.59
股息殖利率
0.46%
股息
10.88

即將到來

股息

0.46%股息殖利率
Jul 26
₹11.00
Aug 25
₹7.00
Sep 24
₹6.00
Sep 23
₹8.00
Aug 22
₹10.00
10年成長
4.33%
5年成長
1.92%
3年成長
11.2%
1年成長
57.14%

財報

29Oct預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
下一步
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

17.07%利潤率
有盈利
2020
2021
2022
2023
2024
2025
3.26B營收
556.39M淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad, India, specializes in the production and commercialization of veterinary vaccines and a comprehensive array of animal health solutions. The company's operations span both domestic and international markets, structured around two primary divisions: Poultry Healthcare and Animal Healthcare. Its extensive range of poultry vaccines targets numerous conditions, including Newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reovirus infections, Marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, and avian encephalomyelitis. For larger animals, Hester Biosciences provides vaccines designed to combat ailments such as Goat Pox, Peste des Petits Ruminants (PPR), Brucellosis, Mastitis, Metritis, various infectious diseases, reproductive disorders, theileriosis, and parasitic infestations. Beyond vaccines, the company's product portfolio encompasses vital feed supplements like toxin binders, trace minerals, enzyme preparations, and bypass fats. It also supplies disinfectants for maintaining farm hygiene and sanitizing equipment, along with water purification solutions. Nutritional support products are offered, including mineral mixtures, fertility boosters, and growth tonics. A significant portion of their offerings consists of herbal preparations, featuring growth promoters, natural alternatives to choline chloride, stress and immunity enhancers, respiratory aids, liver tonics, wound healing agents, uterine and digestive tonics, anti-bloat remedies, ectoparasiticides, and treatments for anti-mastitis and anti-prolapse conditions.
Show more...
執行長
Rajiv Dinesh Gandhi
員工
483
國家
印度
ISIN
INE782E01017

上市

0 Comments

分享你的想法

FAQ

Hester Biosciences 今天的股價是多少?
HESTERBIO.NSE 目前價格為 ₹2,365.00 INR,過去 24 小時下跌了 -1.09%。在圖表上更密切關注 Hester Biosciences 股票的表現。
Hester Biosciences 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 NSE (India) 交易所,Hester Biosciences 的股票以代號 HESTERBIO.NSE 進行交易。
Hester Biosciences 的股價在上漲嗎?
HESTERBIO.NSE 股票較上週上漲 +4.53%,本月下跌 -2.35%,過去一年 Hester Biosciences 上漲 +10.91%。
Hester Biosciences 的市值是多少?
今天 Hester Biosciences 的市值為 20.12B
Hester Biosciences 下一次財報日期是什麼時候?
Hester Biosciences 將於 October 29, 2026 公布下一次財報。
Hester Biosciences 去年的營收是多少?
Hester Biosciences 去年的營收為 3.26BINR。
Hester Biosciences 去年的淨利是多少?
HESTERBIO.NSE 去年的淨收益為 556.39MINR。
Hester Biosciences 會發放股息嗎?
是的,HESTERBIO.NSE 的股息每 年度 發放一次。每股最新股息為 11 INR。截至今日,股息殖利率(FWD)% 為 0.46%。
Hester Biosciences 有多少名員工?
截至 September 07, 2026,公司共有 483 名員工。
Hester Biosciences 位於哪個產業?
Hester Biosciences從事於Health & Wellness產業。
Hester Biosciences 何時完成拆股?
Hester Biosciences 上次拆股發生於 September 27, 2012,比例為 3:2。
Hester Biosciences 的總部在哪裡?
Hester Biosciences 的總部位於 印度 的 Ahmedabad。